CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome

Meshrkey, Fibi, Cabrera Ayuso, Ana, Rao, Raj R., Iyer, Shilpa·2021·Stem Cell Research
DOI 10.1016/j.scr.2021.102572
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.scr.2021.102572

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 88

  1. Armstrong, 2010, Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells, Stem Cells, 28, 661, 10.1002/stem.307 · DOI
  2. Bakare, 2021, Leigh syndrome: a tale of two genomes, Front. Physiol., 12, 10.3389/fphys.2021.693734 · DOI
  3. Bakare, 2021, Quantifying mitochondrial dynamics in patient fibroblasts with multiple developmental defects and mitochondrial disorders, Int. J. Mol. Sci., 22, 10.3390/ijms22126263 · DOI
  4. Baracca, 2007, Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993, Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids, 1767, 913, 10.1016/j.bbabio.2007.05.005 · DOI
  5. Castagna, 2007, Late onset leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA, Am. J. Med. Genet.Part A, 143A, 808, 10.1002/ajmg.a.31637 · DOI
  6. Chan, 2006, Mitochondria: dynamic organelles in disease, aging, and development, Cell, 125, 1241, 10.1016/j.cell.2006.06.010 · DOI · Paper page
  7. Chen, 2017, Mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells, Cell Metab., 26, 39, 10.1016/j.cmet.2017.05.016 · DOI
  8. Cherry, 2013, Induced pluripotent stem cells with a mitochondrial DNA deletion, Stem cells (Dayton, Ohio), 31, 1287, 10.1002/stem.1354 · DOI
  9. Choi, 2015, Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells, Stem Cells Dev., 24, 1366, 10.1089/scd.2014.0561 · DOI
  10. Cottet-Rousselle, 2011, Cytometric assessment of mitochondria using fluorescent probes, Cytometry A, 79, 405, 10.1002/cyto.a.21061 · DOI
  11. Dahan, 2019, Metabolism in pluripotency: both driver and passenger?, J. Biol. Chem., 294, 5420, 10.1074/jbc.TM117.000832 · DOI
  12. D'Aurelio, 2010, Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells, Hum. Mol. Genet., 19, 374, 10.1093/hmg/ddp503 · DOI
  13. Debray, 2007, Long-term outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation, Am. J. Med. Genet. A, 143A, 2046, 10.1002/ajmg.a.31880 · DOI
  14. Duchen, 2004, Roles of mitochondria in health and disease, Diabetes, 53, S96, 10.2337/diabetes.53.2007.S96 · DOI
  15. Esteras, 2020, Visualization of mitochondrial membrane potential in mammalian cells, Methods Cell Biol., 155, 221, 10.1016/bs.mcb.2019.10.003 · DOI
  16. Folmes, 2011, Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming, Cell Metab., 14, 264, 10.1016/j.cmet.2011.06.011 · DOI
  17. Folmes, 2013, Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS, Stem Cells, 31, 1298, 10.1002/stem.1389 · DOI
  18. Galera, 2016, Generation of a human iPSC line from a patient with Leigh syndrome, Stem Cell Res., 16, 63, 10.1016/j.scr.2015.12.005 · DOI
  19. Galera-Monge, 2016, Generation of a human iPSC line from a patient with Leigh syndrome caused by a mutation in the MT-ATP6 gene, Stem Cell Res., 16, 766, 10.1016/j.scr.2016.04.012 · DOI
  20. Galera-Monge, 2020, Mitochondrial dysfunction and calcium dysregulation in leigh syndrome induced pluripotent stem cell derived neurons, Int. J. Mol. Sci., 21, 10.3390/ijms21093191 · DOI
  21. Gao, 2017, Abnormalities of mitochondrial dynamics in neurodegenerative diseases, Antioxidants (Basel), 6
  22. Grace, 2019, mRNA reprogramming of T8993G Leigh's syndrome fibroblast cells to create induced pluripotent stem cell models for mitochondrial disorders, Stem Cells Dev., 28, 846, 10.1089/scd.2019.0045 · DOI
  23. Harwig, 2018, Methods for imaging mammalian mitochondrial morphology: a prospective on MitoGraph, Anal. Biochem., 552, 81, 10.1016/j.ab.2018.02.022 · DOI
  24. Hattori, 2016, Metabolic signature of MELAS/leigh overlap syndrome in patient-specific induced pluripotent stem cells model, Osaka City Med. J., 62, 69
  25. Hoppel, 2009, Dynamic organization of mitochondria in human heart and in myocardial disease, Int. J. Biochem. Cell Biol., 41, 1949, 10.1016/j.biocel.2009.05.004 · DOI
  26. Iannetti, 2015, Toward high-content screening of mitochondrial morphology and membrane potential in living cells, Int. J. Biochem. Cell Biol., 63, 66, 10.1016/j.biocel.2015.01.020 · DOI
  27. Inak, 2021, Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome, Nat. Commun., 12, 1929, 10.1038/s41467-021-22117-z · DOI
  28. Iyer, 2009, Stem cell-based models and therapies for neurodegenerative diseases, Crit. Rev. Biomed. Eng., 37, 321, 10.1615/CritRevBiomedEng.v37.i4-5.20 · DOI
  29. Khacho, 2017, Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis, Hum. Mol. Genet., 26, 3327, 10.1093/hmg/ddx217 · DOI
  30. Kirby, 2003, Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease, Ann. Neurol., 54, 473, 10.1002/ana.10687 · DOI
  31. Kiryu-Seo, 2016, Mitochondrial fission is an acute and adaptive response in injured motor neurons, Sci. Rep., 6, 28331, 10.1038/srep28331 · DOI
  32. Koopman, 2005, Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency, Am. J. Physiol. Cell Physiol., 289, C881, 10.1152/ajpcell.00104.2005 · DOI
  33. Kori, 2019, Transition from Leigh syndrome to MELAS syndrome in a patient with heteroplasmic MT-ND3 m.10158T>C, Brain Dev., 41, 803, 10.1016/j.braindev.2019.05.006 · DOI
  34. Lake, 2016, Leigh syndrome: one disorder, more than 75 monogenic causes, Ann. Neurol., 79, 190, 10.1002/ana.24551 · DOI
  35. Legros, 2002, Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins, Mol. Biol. Cell, 13, 4343, 10.1091/mbc.e02-06-0330 · DOI
  36. Leigh, 1951, Subacute necrotizing encephalomyelopathy in an infant, J. Neurol. Neurosurg. Psychiatry, 14, 216, 10.1136/jnnp.14.3.216 · DOI
  37. Liu, 2009, Ca2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex, Int. J. Biochem. Cell Biol., 41, 1972, 10.1016/j.biocel.2009.05.013 · DOI
  38. Loeffen, 2000, Isolated complex I deficiency in children: clinical, biochemical and genetic aspects, Hum. Mutat., 15, 123, 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P · DOI
  39. Ma, 2015, Metabolic rescue in pluripotent cells from patients with mtDNA disease, Nature, 524, 234, 10.1038/nature14546 · DOI
  40. Mah, 2011, Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network, PLoS ONE, 6, 10.1371/journal.pone.0024351 · DOI
  41. McCarron, 2013, From structure to function: mitochondrial morphology, motion and shaping in vascular smooth muscle, J. Vasc. Res., 50, 357, 10.1159/000353883 · DOI
  42. McFarland, 2004, De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency, Ann. Neurol., 55, 58, 10.1002/ana.10787 · DOI
  43. Mitchell, 1966, Chemiosmotic coupling in oxidative and photosynthetic phosphorylation, Biol. Rev. Camb. Philos. Soc., 41, 445, 10.1111/j.1469-185X.1966.tb01501.x · DOI
  44. Mitra, 2009, A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase, Proc. Natl. Acad. Sci. U.S.A., 106, 11960, 10.1073/pnas.0904875106 · DOI
  45. Mortiboys, 2008, Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts, Ann. Neurol., 64, 555, 10.1002/ana.21492 · DOI
  46. Nakada, 2001, Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA, Nat. Med., 7, 934, 10.1038/90976 · DOI
  47. Nesbitt, 2012, The clinical spectrum of the m.10191T>C mutation in complex I-deficient Leigh syndrome, Dev. Med. Child Neurol., 54, 500, 10.1111/j.1469-8749.2012.04224.x · DOI
  48. Ni, 2015, Mitochondrial dynamics and mitochondrial quality control, Redox Biol., 4, 6, 10.1016/j.redox.2014.11.006 · DOI · Paper page
  49. Ogawa, 2003, Starvation induces the formation of giant mitochondria in gastric parietal cells of guinea pigs, J. Electron. Microsc. (Tokyo), 52, 217, 10.1093/jmicro/52.2.217 · DOI
  50. Picard, 2013, Mitochondrial morphology transitions and functions: implications for retrograde signaling?, Am. J. Physiol. Regul. Integr. Comp. Physiol., 304, R393, 10.1152/ajpregu.00584.2012 · DOI
  51. Piekutowska-Abramczuk, 2018, Leigh syndrome in individuals bearing m.9185T>C MTATP6 variant. Is hyperventilation a factor which starts its development?, Metab. Brain Dis., 33, 191, 10.1007/s11011-017-0122-1 · DOI
  52. Prigione, 2010, The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells, Stem Cells, 28, 721, 10.1002/stem.404 · DOI
  53. Prigione, 2011, Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations, PLoS ONE, 6, 10.1371/journal.pone.0027352 · DOI
  54. S. Rahman, D. Thorburn, Nuclear Gene-Encoded Leigh Syndrome Spectrum Overview, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, G. Mirzaa, A. Amemiya (Eds.) GeneReviews((R)), Seattle (WA), 1993.
  55. Rambold, 2011, Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation, Proc. Natl. Acad. Sci. U.S.A., 108, 10190, 10.1073/pnas.1107402108 · DOI
  56. Rasmussen, 2018, A non-apoptotic function of MCL-1 in promoting pluripotency and modulating mitochondrial dynamics in stem cells, Stem Cell Rep., 10, 684, 10.1016/j.stemcr.2018.01.005 · DOI
  57. Rastogi, 2019, Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming, Cell Stress, 3, 181, 10.15698/cst2019.06.189 · DOI
  58. Rolland, 2013, Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion, Proc. Natl. Acad. Sci. U.S.A., 110, E2967, 10.1073/pnas.1303872110 · DOI
  59. Salisbury-Ruf, 2018, Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study, Elife, 7, 10.7554/eLife.40907 · DOI
  60. Scaduto, 1999, Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives, Biophys. J., 76, 469, 10.1016/S0006-3495(99)77214-0 · DOI
  61. Schieke, 2008, Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells, J. Biol. Chem., 283, 28506, 10.1074/jbc.M802763200 · DOI
  62. Seo, 2018, Mitochondrial dynamics in stem cells and differentiation, Int. J. Mol. Sci., 19, 10.3390/ijms19123893 · DOI
  63. Sequiera, 2020, Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene, Stem Cell Res., 48
  64. Sequiera, 2020, Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene, Stem Cell Res., 48
  65. Son, 2013, Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency, Stem Cells, 31, 2374, 10.1002/stem.1509 · DOI
  66. Son, 2015, Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency, Cell Death Differ., 22, 1957, 10.1038/cdd.2015.43 · DOI
  67. Son, 2021, Self-replicative mRNA-mediated generation of induced pluripotent stem cell line from a 1-year-old Leigh syndrome patient with mitochondrial DNA cytochrome b mutation, Stem Cell Res., 54, 10.1016/j.scr.2021.102392 · DOI
  68. Sprenger, 2019, The good and the bad of mitochondrial breakups, Trends Cell Biol., 29, 888, 10.1016/j.tcb.2019.08.003 · DOI
  69. Suhr, 2010, Mitochondrial rejuvenation after induced pluripotency, PLoS ONE, 5, 10.1371/journal.pone.0014095 · DOI
  70. Taylor, 2002, Leigh disease associated with a novel mitochondrial DNA ND5 mutation, Eur. J. Hum. Genet., 10, 141, 10.1038/sj.ejhg.5200773 · DOI
  71. Tokuyama, 2020, Mitochondrial dynamics regulation in skin fibroblasts from mitochondrial disease patients, Biomolecules, 10, 10.3390/biom10030450 · DOI
  72. Tsogtbaatar, 2020, Energy metabolism regulates stem cell pluripotency, Front. Cell Dev. Biol., 8, 87, 10.3389/fcell.2020.00087 · DOI
  73. Uziel, 1997, Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families, J. Neurol. Neurosurg. Psychiatry, 63, 16, 10.1136/jnnp.63.1.16 · DOI
  74. Valente, 2017, A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture, Acta Histochem., 119, 315, 10.1016/j.acthis.2017.03.001 · DOI
  75. Varum, 2011, Energy metabolism in human pluripotent stem cells and their differentiated counterparts, PLoS ONE, 6, 10.1371/journal.pone.0020914 · DOI · Paper page
  76. Vodopivec, 2016, Mitochondrial encephalopathy and optic neuropathy due to m.10158 MT-ND3 complex i mutation presenting in an adult patient: case report and review of the literature, Neurologist, 21, 61, 10.1097/NRL.0000000000000084 · DOI
  77. Wai, 2016, Mitochondrial dynamics and metabolic regulation, Trends Endocrinol. Metab., 27, 105, 10.1016/j.tem.2015.12.001 · DOI
  78. Wallace, 1999, Mitochondrial diseases in man and mouse, Science, 283, 1482, 10.1126/science.283.5407.1482 · DOI · Paper page
  79. Wang, 2017, Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission, EMBO J., 36, 1330, 10.15252/embj.201695417 · DOI
  80. Willems, 2015, Redox homeostasis and mitochondrial dynamics, Cell Metab., 22, 207, 10.1016/j.cmet.2015.06.006 · DOI
  81. Yoneda, 1994, Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles, Mol. Cell. Biol., 14, 2699
  82. Youle, 2012, Mitochondrial fission, fusion, and stress, Science, 337, 1062, 10.1126/science.1219855 · DOI · Paper page
  83. Zemirli, 2018, Mitochondrial Dynamics in Basal and Stressful Conditions, Int. J. Mol. Sci., 19, 10.3390/ijms19020564 · DOI
  84. Zhadanov, 2007, Fatal manifestation of a de novo ND5 mutation: insights into the pathogenetic mechanisms of mtDNA ND5 gene defects, Mitochondrion, 7, 260, 10.1016/j.mito.2007.01.003 · DOI
  85. Zhang, 2011, UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells, EMBO J., 30, 4860, 10.1038/emboj.2011.401 · DOI
  86. Zhang, 2018, Metabolism in pluripotent stem cells and early mammalian development, Cell Metab., 27, 332, 10.1016/j.cmet.2018.01.008 · DOI
  87. Zinovkin, 2016, Mitochondrial genome and longevity, Biochemistry (Mosc), 81, 1401, 10.1134/S0006297916120014 · DOI
  88. Zorova, 2018, Mitochondrial membrane potential, Anal. Biochem., 552, 50, 10.1016/j.ab.2017.07.009 · DOI

Cited by

Sorted by citations

See all 24

Metadata

Authors
Meshrkey, F., Cabrera Ayuso, A., Rao, R. R., & Iyer, S.
Venue
Stem Cell Research
Publisher
Elsevier BV
Published
2021-12
Volume
57
Pages
102572
ISSN
1873-5061
DOI
10.1016/j.scr.2021.102572
Cited by
24
References
1
Language
en
Licence
Funders
  • Arkansas Biosciences Institute
  • Medizinische Universität Innsbruck
  • U.S. Department of Defense (W81XWH-16-1-0181)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review